Menu

Worldwide global commercial footprint1

Over 75 countries covered through three sales channels:

  • Direct sales force covering Western European countries, USA and Canada
  • Distributor relationships in place covering ~60 countries. Distribution agreement with Nichirei Biosciences for Japanese market.
  • Joint venture in China with Wondfo

Local representation

Light blue: commercialization through joint venture
Blue: commercialization through direct sales force 
Dark blue: commercialization through distribution partners

  • 1Situation as per 31 December 2021
Worldwide global commercial footprint Biocartis
Partners Biocartis

Partnering

Biocartis believes in the power of collaboration and has partnership programs with pharmaceutical and diagnostic or biomarker companies
Learn more
Pharma Partnering Biocartis

Pharma partnering

Biocartis aims to help improve patient access to molecular diagnostics tests that drive treatment decisions.
Learn more
Partnering Biocartis

Content partnering

Biocartis supports its partners to make their biomarker tests available to customers worldwide.
Learn more